fda warning letter bpc-157 compounding pharmacy of the Federal Food, Drug, and Cosmetic Act (FDCA).* FDA to weigh easing limits
Description
This will prevent future tears in the tendon
Knee Osteoarthritis: Multiple high-quality studies indicate that PRP provides significant symptomatic relief in knee osteoarthritis, with benefits lasting up to 12 months post-injection (PMID: 39429381)
Some of the peptide may be broken down before it can exert its full effect on systemic tissues outside the gut
doi:10.1111/andr.12191
Thats where treatments like spinal decompression may play a role
